Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT06957548

Cardiometabolic Disease Risk Factors in Cameroon

Cardiometabolic diseases (CMDs) are a major public health concern in sub-Saharan Africa, including Cameroon. Studies have shown a significant increase in the prevalence of hypertension, diabetes, and obesity in recent years. However, access to timely diagnosis and treatment remains limited, particularly in rural areas. Community-based screening programs have been shown to be effective in identifying individuals with undiagnosed CMD risk factors and promoting early intervention. By leveraging the strengths of community-based approaches, the URBACAM-D study aims to address the growing burden of CMDs in urban Cameroon.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Newbell Protestant Hospital

Douala, Littoral Region, Cameroon

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Screening is open to any adult over the age of 18 years

Treatment and study plan

Cardiometabolic disease

Diagnostic Test

Cardiometabolic disease screening

Primary outcomes

  1. Prevalence of Cardiometabolic disease risk factors in Urban Cameroon

    Time frame: 1 year

    To determine the prevalence of undiagnosed and uncontrolled cardiometabolic disease (CMD) risk factors among urban Cameroonians.

Sponsors and collaborators

Lead sponsor

Johns Hopkins University

Other

Registry information

Official study title

Screening for Cardiometabolic Disease Risk Factors: a Community Health Screening Program in Urban Cameroon

Acronym: URBACAM-D

Important dates

Study start
2025
Primary completion
2025
Study completion
2027
First posted
May 4, 2025
Registry last updated
Nov 26, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.